Myricx Pharma Ltd Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Myricx Pharma Ltd is a UK biotechnology company based in Kings Cross, London, England. It focuses on discovering and developing a new class of selective cytotoxic payloads for antibody-drug conjugates, underpinned by inhibitors of N-myristoyltransferases to treat cancer. These payloads are intended to advance ADC therapies and support developers pursuing oncology treatments. The company operates in the biotechnology research sector as a small to mid-sized enterprise. In September 2025, Mohit Rawat was appointed CEO, marking a leadership change.